Loading markets…

TG Therapeutics, Inc. (TGTX) forecast

TG Therapeutics, Inc. (TGTX) forecast: price $52.84, trailing P/E 17.47, forward P/E 52.86. How to read the street's path.

$52.84Price
$8.09BMarket cap
17.47P/E ?
52.86Forward P/E ?
0.00%Dividend yield ?

The live TGTX price is $52.84. Trailing P/E is 17.47 and forward P/E is 52.86. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the TGTX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full TGTX quote · Dividends · Price prediction · Academy

Questions

What is TGTX's forward P/E?

The latest forward P/E on Stocklytics is 52.86, against a trailing P/E of 17.47 and a price of $52.84.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.